This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a ceiling value of $22,814.81 and a performance period through March 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The contract has a ceiling value of $43,686.89 and a period of performance through May 6, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $25,503.51 and an ultimate completion date of August 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is valued at $12,604.63 and has an ultimate completion date of February 4, 2025. The contract covers the provision of SKYRIZI 180 MG/1.2 ML ON-BODY 1.2ML, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a medication. The contract has a firm fixed price of $34,934.73 and a completion date of May 27, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $57,275.66 firm-fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a completion date of May 21, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a firm fixed price ceiling value of $56,561.02 and a performance period ending on May 16, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a ceiling value of $48,464.29 and a period of performance through May 16, 2025. The contract is a Firm Fixed Price type and was not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide SKYRIZI 150 MG/ML PENML medication. The $19,325.21 firm fixed-price contract has a completion date of May 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product, with a ceiling value of $20,065.52 and a period of performance through June 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant...